HRMY- Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. (HRMY) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. HRMY is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 24.5K | $759.9K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Kapadia Sandip71 | Chief Financial Officer | Sell | 3,746 | $37.15 | $139,171.39 | -13.3% | - | - | |
| Dec 12, 2025 | Dayno Jeffrey M.54 | President, CEO | Sale+OE | 25,933 | $40.11 | $1,040,102.61 | -100% | -31.4% | - | |
| Dec 5, 2025 | Kapadia Sandip71 | Chief Financial Officer | Sale+OE | 20,000 | $39.54 | $790,896.00 | -100% | -28.4% | - | |
| Nov 21, 2025 | Kapadia Sandip71 | Chief Financial Officer | Sell | 3,427 | $35.00 | $119,945.00 | -100% | +0.2% | - | |
| Aug 15, 2025 | Kapadia Sandip71 | Chief Financial Officer | Sell | 21,573 | $36.50 | $787,377.83 | -100% | -7.0% | - | |
| Apr 1, 2025 | Kapadia Sandip71 | Chief Financial Officer | Sell | 6,987 | $32.54 | $227,385.94 | -90.4% | -2.5% | -13.8% | |
| Mar 3, 2025 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 4,869 | $32.67 | $159,089.50 | -90.7% | +10.5% | -12.1% | |
| Jan 27, 2025 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 14,754 | $37.38 | $551,575.01 | -74.2% | -23.2% | -1.5% | |
| Jan 27, 2025 | Kapadia Sandip71 | Chief Financial Officer | Sale+OE | 1,775 | $38.05 | $67,547.27 | -100% | -23.2% | -1.5% | |
| Jan 21, 2025 | Dayno Jeffrey M.54 | President, CEO | Sale+OE | 19,293 | $40.13 | $774,245.45 | -100% | -29.6% | -9.3% |
Page 1Next →